1
|
Ferea CR, Mihai SN, Balan G, Badescu MC, Tutunaru D, Tatu AL. Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach. Life (Basel) 2023; 13:809. [PMID: 36983964 PMCID: PMC10053503 DOI: 10.3390/life13030809] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Revised: 03/03/2023] [Accepted: 03/14/2023] [Indexed: 03/19/2023] Open
Abstract
Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones, muscles, eyes, ears, mouth, heart, lung, liver, kidneys, intestines, and spleen may be affected by SS as extracutaneous manifestations. More and more cases have been found to be associated with malignancies, particularly myelodysplastic syndrome, and, less frequently, other hematologic malignancies or solid tumors. Approximately 21% of patients with SS have an associated malignancy and up to 80% of MASS cases are associated with hematological diseases, predominantly myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Myelodysplastic syndrome is a clonal disease of the bone marrow characterized by inefficient hematopoiesis, dysplasia of the bone marrow and peripheral cytopenias. Affected patients have a high risk of leukemic transformation. After analyzing later studies and current practical aspects regarding MDS-related SS, we suggest an algorithm for evaluating these patients.
Collapse
Affiliation(s)
- Cătălina Roxana Ferea
- Faculty of Medicine, “Carol Davila” University of Medicine and Farmacy, 020021 Bucharest, Romania
- Hematology Department, University Emergency Hospital, 050098 Bucharest, Romania
- Faculty of Medicine and Pharmacy, ”Dunărea de Jos” University of Galați, 800008 Galați, Romania
| | - Stejara Nicoleta Mihai
- Faculty of Medicine, “Carol Davila” University of Medicine and Farmacy, 020021 Bucharest, Romania
- Hematology Department, University Emergency Hospital, 050098 Bucharest, Romania
| | - Gabriela Balan
- Faculty of Medicine and Pharmacy, ”Dunărea de Jos” University of Galați, 800008 Galați, Romania
- Gastroenterology Department, “Sf. Apostol Andrei” County Emergency Clinical Hospital Galați, 800578 Galați, Romania
| | - Minerva Codruta Badescu
- Department of Internal Medicine, “Grigore T. Popa” University of Medicine and Farmacy, 700115 Iași, Romania
- III Internal Medicine Clinic, “Sf. Spiridon” County Emergency Clinical Hospital, 700111 Iași, Romania
| | - Dana Tutunaru
- Faculty of Medicine and Pharmacy, ”Dunărea de Jos” University of Galați, 800008 Galați, Romania
- Laboratory Department, “Sf. Apostol Andrei” County Emergency Clinical Hospital Galați, 800578 Galați, Romania
| | - Alin Laurențiu Tatu
- Faculty of Medicine and Pharmacy, ”Dunărea de Jos” University of Galați, 800008 Galați, Romania
- Dermatology Department, Clinical Hospital of Infectious Diseases “Sf. Cuvioasa Parascheva” Galați, 800179 Galați, Romania
- Multidisciplinary Integrated Center of Dermatological Interface Research MIC DIR, Dunărea de Jos” University, 800008 Galați, Romania
| |
Collapse
|
2
|
Magdoud O, Souissi A, Chelly I, Haouet S, Mokni M. [Pyoderma gangrenosum and systemic lupus erythematosus: A rare association]. Rev Med Interne 2019; 41:54-57. [PMID: 31495525 DOI: 10.1016/j.revmed.2019.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2019] [Revised: 08/03/2019] [Accepted: 08/06/2019] [Indexed: 10/26/2022]
Abstract
INTRODUCTION Pyoderma gangrenosum (PG) is a neutrophilic dermatosis that is traditionally associated with systemic disorders such as chronic inflammatory bowel diseases, rheumatoid arthritis and malignant hematologic disorders. Its association with systemic lupus erythematosus (SLE) is rare and not well known. We report a case of this association with a review of the literature. CASE REPORT A 43-year-old female patient, followed for 4 years for SLE, presented a deep ulceration of the anterior face of the left thigh with inflammatory borders, an ulcerated nodule of the right shoulder and four small ulcerations of the back of the right hand. The biopsy of the ulceration of the left thigh concluded to PG. The patient was treated by corticosteroids with complete healing of lesions. CONCLUSION The prognosis of lupus does not seem to be aggravated by PG and the treatments of a SLE flare are usually enough for treating associated PG.
Collapse
Affiliation(s)
- O Magdoud
- Dermatology department, La Rabta Hospital, Tunis, Tunisia.
| | - A Souissi
- Dermatology department, La Rabta Hospital, Tunis, Tunisia
| | - I Chelly
- Pathology department, La Rabta Hospital, Tunis, Tunisia
| | - S Haouet
- Pathology department, La Rabta Hospital, Tunis, Tunisia
| | - M Mokni
- Dermatology department, La Rabta Hospital, Tunis, Tunisia
| |
Collapse
|